Blue Heron Biotech is a gene synthesis company with a proprietary technology called GeneMaker® that fully automates the synthesis process allowing for scalability and faster production times. Blue Heron has built a steady business by continually decreasing the cost to synthesize DNA making it better for companies to outsource this input. These cheaper products make it possible for academic and pharmaceutical researchers to order thousands of variations of genes to be used in laboratory testing. In 2019, Eurofins Genomics, a global leader in oligonucleotide synthesis, Sanger sequencing, next generation sequencing, and gene synthesis acquired Blue Heron Biotech for an undisclosed sum.